Guidelines: NCCN Guidelines (Poland): Difference between revisions
m (Victor moved page NCCN Guidelines (Poland) to Guidelines: NCCN Guidelines (Poland)) |
m (Update categories.) |
||
| (4 intermediate revisions by the same user not shown) | |||
| Line 48: | Line 48: | ||
<span style="display:none">availableVariable::quality of life</span> | <span style="display:none">availableVariable::quality of life</span> | ||
<span style="display:none">availableVariable::diagnosis|skin cancer</span> | <span style="display:none">availableVariable::diagnosis|skin cancer</span> | ||
<span style="display:none">isPracticeGuideline</span> | |||
<span style="display:none">hasCancerType::C50: Breast cancer</span> | <span style="display:none">hasCancerType::C50: Breast cancer</span> | ||
<span style="display:none">hasCancerType::C15-C26: Digestive system cancers</span> | <span style="display:none">hasCancerType::C15-C26: Digestive system cancers</span> | ||
| Line 53: | Line 54: | ||
<span style="display:none">hasCancerType::C30-C39: Lung/chest cancers</span> | <span style="display:none">hasCancerType::C30-C39: Lung/chest cancers</span> | ||
<span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span> | <span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span> | ||
<span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | |||
<span style="display:none">hasCancerType::C00-C97: All cancer types</span> | |||
<span style="display:none">Esophageal</span> | |||
<span style="display:none">Gastric</span> | |||
<span style="display:none">Intestinal</span> | |||
<span style="display:none">Bowel</span> | |||
<span style="display:none">Colorectal</span> | |||
<span style="display:none">Appendix</span> | |||
<span style="display:none">Appendiceal</span> | |||
<span style="display:none">Duodenum</span> | |||
<span style="display:none">Jejunum</span> | |||
<span style="display:none">Ileum</span> | |||
<span style="display:none">Anal</span> | |||
<span style="display:none">Perianal</span> | |||
<span style="display:none">Hepatic</span> | |||
<span style="display:none">Biliary</span> | |||
<span style="display:none">Hepatobiliary</span> | |||
<span style="display:none">Cutaneous</span> | |||
<span style="display:none">Dermal</span> | |||
<span style="display:none">Epidermal</span> | |||
<span style="display:none">Axilla</span> | |||
<span style="display:none">Axillary</span> | |||
<span style="display:none">Mammary</span> | |||
<span style="display:none">Prostatic</span> | |||
<span style="display:none">Testicular</span> | |||
<span style="display:none">Penile</span> | |||
Latest revision as of 12:04, 14 December 2025
Go back to Poland page
Primary purpose: To assist clinicians in determining appropriate and effective avenues of care.
Sponsor, manager or home institution: National Comprehensive Cancer Network (NCCN) and Norodowy Intytut Onkologii.
Type of information: It contains clinical recommendations, treatments, follow up, quality of life, of breast cancer, colon cancer, melanoma, non-small cell lung cancer, prostate cancer and squamous cell skin cancer.
Cancer areas of interest: C50: Breast cancer,C15-C26: Digestive system cancers, C43-C44: Skin cancers/melanoma, C30-C39: Lung/chest cancers, C60-C63: Male genitalia cancer. Click here to learn more
Access to information: Click here to access, in European editions: Poland (Is necessary to create a login to access the information).